Cleared Traditional

K223514 - Spectral Bone Marrow

K223514 is the FDA 510(k) clearance for Spectral Bone Marrow by Ge Medical Systems, LLC. It is a Class 2 Radiology device (product code JAK) cleared through the Traditional 510(k) pathway after a 107-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
107d
Days
Class 2
Risk

K223514 is an FDA 510(k) clearance for the Spectral Bone Marrow. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Ge Medical Systems, LLC (Waukesha, US). The FDA issued a Cleared decision on March 9, 2023 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ge Medical Systems, LLC devices

Submission Details

510(k) Number K223514 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 22, 2022
Decision Date March 09, 2023
Days to Decision 107 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
At panel average
Panel avg: 107d · This submission: 107d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 581
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K223514.
iCAC Device
K230223 · Bunkerhill, Inc. · Apr 2023
Deep Learning Image Reconstruction
K230807 · Ge Healthcare Japan Corporation · Apr 2023
AI-Rad Companion (Cardiovascular)
K222360 · Siemens Medical Solutions U.S.A. · Apr 2023
Aquilion Precision (TSX-304A/4) V10.14 with AiCE
K223726 · Canon Medical Systems Corporation · Mar 2023
Aquilion Serve (TSX-307A/1) V1.2 with AiCE-i
K222819 · Canon Medical Systems Corporation · Mar 2023
uCT ATLAS Astound with uWS-CT-Dual Energy Analysis
K223028 · Shanghai United Imaging Healthcare Co., Ltd. · Feb 2023